LEXIVA - 49349-811-02 - (fosamprenavir calcium)

Alphabetical Index


Drug Information of LEXIVA

Product NDC: 49349-811
Proprietary Name: LEXIVA
Non Proprietary Name: fosamprenavir calcium
Active Ingredient(s): 700    mg/1 & nbsp;   fosamprenavir calcium
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of LEXIVA

Product NDC: 49349-811
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021548
Marketing Category: NDA
Start Marketing Date: 20130509

Package Information of LEXIVA

Package NDC: 49349-811-02
Package Description: 30 TABLET, FILM COATED in 1 BLISTER PACK (49349-811-02)

NDC Information of LEXIVA

NDC Code 49349-811-02
Proprietary Name LEXIVA
Package Description 30 TABLET, FILM COATED in 1 BLISTER PACK (49349-811-02)
Product NDC 49349-811
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name fosamprenavir calcium
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130509
Marketing Category Name NDA
Labeler Name REMEDYREPACK INC.
Substance Name FOSAMPRENAVIR CALCIUM
Strength Number 700
Strength Unit mg/1
Pharmaceutical Classes HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]

Complete Information of LEXIVA


General Information